 Patricia Ernst
Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myeloid-Lymphoid Leukemia Protein | 29 | 2021 | 64 | 8.590 |
Why?
| | Histone-Lysine N-Methyltransferase | 27 | 2021 | 99 | 7.570 |
Why?
| | Hematopoiesis | 12 | 2017 | 176 | 2.820 |
Why?
| | Hematopoietic Stem Cells | 14 | 2019 | 358 | 2.680 |
Why?
| | Leukemia | 8 | 2021 | 208 | 2.040 |
Why?
| | Leukemia, Myeloid, Acute | 8 | 2021 | 539 | 1.690 |
Why?
| | Gene Expression Regulation, Leukemic | 6 | 2021 | 48 | 1.450 |
Why?
| | Oncogene Proteins, Fusion | 6 | 2019 | 177 | 1.430 |
Why?
| | Gene Rearrangement | 3 | 2021 | 140 | 1.350 |
Why?
| | Proto-Oncogene Proteins | 7 | 2021 | 615 | 1.250 |
Why?
| | Epigenesis, Genetic | 3 | 2015 | 546 | 1.060 |
Why?
| | DNA-Binding Proteins | 8 | 2021 | 1340 | 1.050 |
Why?
| | Transcription Factors | 11 | 2023 | 1557 | 0.980 |
Why?
| | Neoplasm Proteins | 4 | 2017 | 396 | 0.940 |
Why?
| | Histones | 5 | 2017 | 544 | 0.910 |
Why?
| | B-Lymphocytes | 2 | 2018 | 771 | 0.740 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 66 | 0.730 |
Why?
| | Cell Transformation, Neoplastic | 4 | 2021 | 311 | 0.710 |
Why?
| | Immunotherapy, Adoptive | 1 | 2021 | 192 | 0.680 |
Why?
| | Proto-Oncogenes | 5 | 2005 | 27 | 0.630 |
Why?
| | Sirtuin 1 | 2 | 2015 | 31 | 0.620 |
Why?
| | Methyltransferases | 2 | 2016 | 60 | 0.620 |
Why?
| | Animals | 39 | 2021 | 32737 | 0.620 |
Why?
| | Interleukin-7 | 1 | 2018 | 44 | 0.610 |
Why?
| | Mice | 32 | 2021 | 15309 | 0.610 |
Why?
| | Histone Chaperones | 1 | 2016 | 14 | 0.570 |
Why?
| | Cell Differentiation | 7 | 2019 | 1730 | 0.560 |
Why?
| | Hematologic Neoplasms | 1 | 2017 | 133 | 0.530 |
Why?
| | Cell Proliferation | 11 | 2019 | 2236 | 0.500 |
Why?
| | Leukemia, Experimental | 1 | 2014 | 27 | 0.490 |
Why?
| | Methylation | 7 | 2019 | 204 | 0.490 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 238 | 0.390 |
Why?
| | Genes, Homeobox | 3 | 2006 | 51 | 0.370 |
Why?
| | Mice, Inbred C57BL | 10 | 2021 | 4839 | 0.350 |
Why?
| | Embryo, Mammalian | 3 | 2005 | 218 | 0.350 |
Why?
| | Signal Transduction | 6 | 2018 | 4606 | 0.350 |
Why?
| | Chromatin | 4 | 2016 | 438 | 0.350 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2004 | 805 | 0.350 |
Why?
| | Cells, Cultured | 11 | 2019 | 3956 | 0.340 |
Why?
| | Mice, Knockout | 10 | 2021 | 2648 | 0.320 |
Why?
| | Interferon-alpha | 1 | 2009 | 191 | 0.310 |
Why?
| | Homeodomain Proteins | 8 | 2016 | 466 | 0.300 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2019 | 267 | 0.300 |
Why?
| | Mice, Transgenic | 6 | 2019 | 1993 | 0.300 |
Why?
| | Stem Cells | 3 | 2009 | 547 | 0.280 |
Why?
| | Carcinogenesis | 2 | 2019 | 183 | 0.280 |
Why?
| | Tumor Suppressor Proteins | 2 | 2021 | 286 | 0.280 |
Why?
| | Gene Expression Regulation | 5 | 2017 | 2408 | 0.270 |
Why?
| | Lymphocyte Activation | 2 | 2018 | 1063 | 0.250 |
Why?
| | Oncogene Proteins | 2 | 2016 | 52 | 0.250 |
Why?
| | HEK293 Cells | 4 | 2021 | 626 | 0.240 |
Why?
| | Trans-Activators | 3 | 2021 | 374 | 0.240 |
Why?
| | Promoter Regions, Genetic | 5 | 2023 | 1141 | 0.240 |
Why?
| | Homeostasis | 3 | 2018 | 588 | 0.240 |
Why?
| | Neuronal Plasticity | 2 | 2016 | 215 | 0.230 |
Why?
| | Humans | 24 | 2021 | 117052 | 0.210 |
Why?
| | Zinc Fingers | 1 | 2002 | 46 | 0.210 |
Why?
| | Pluripotent Stem Cells | 1 | 2023 | 65 | 0.210 |
Why?
| | Multiprotein Complexes | 2 | 2014 | 148 | 0.210 |
Why?
| | Tumor Escape | 1 | 2021 | 37 | 0.190 |
Why?
| | Chromatin Assembly and Disassembly | 2 | 2014 | 93 | 0.190 |
Why?
| | Antigens, CD19 | 1 | 2021 | 97 | 0.190 |
Why?
| | Precursor Cells, B-Lymphoid | 2 | 2018 | 34 | 0.180 |
Why?
| | Alleles | 3 | 2014 | 816 | 0.180 |
Why?
| | Enterotoxins | 1 | 2000 | 86 | 0.180 |
Why?
| | Myogenic Regulatory Factor 5 | 1 | 2019 | 5 | 0.180 |
Why?
| | PAX7 Transcription Factor | 1 | 2019 | 9 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-bcl-6 | 1 | 2019 | 6 | 0.170 |
Why?
| | MDS1 and EVI1 Complex Locus Protein | 1 | 2019 | 6 | 0.170 |
Why?
| | Lymphopoiesis | 2 | 2013 | 24 | 0.170 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2019 | 26 | 0.170 |
Why?
| | Gene Deletion | 2 | 2019 | 356 | 0.170 |
Why?
| | Antineoplastic Agents | 2 | 2021 | 1941 | 0.170 |
Why?
| | Myoblasts | 1 | 2019 | 74 | 0.160 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 2 | 2011 | 30 | 0.160 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 646 | 0.160 |
Why?
| | Tamoxifen | 1 | 2019 | 196 | 0.160 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2019 | 535 | 0.160 |
Why?
| | Interleukin-10 | 1 | 2000 | 299 | 0.150 |
Why?
| | Multigene Family | 2 | 2017 | 198 | 0.150 |
Why?
| | T-Lymphocyte Subsets | 1 | 2000 | 386 | 0.150 |
Why?
| | Enzyme Inhibitors | 1 | 2021 | 775 | 0.150 |
Why?
| | Apoptosis | 2 | 2011 | 2433 | 0.140 |
Why?
| | Neurons | 3 | 2016 | 1309 | 0.140 |
Why?
| | Antigens, CD | 2 | 2013 | 450 | 0.140 |
Why?
| | Nuclear Pore Complex Proteins | 1 | 2016 | 34 | 0.140 |
Why?
| | Protein Interaction Maps | 1 | 2016 | 37 | 0.140 |
Why?
| | Organ Specificity | 1 | 2017 | 270 | 0.140 |
Why?
| | Dopamine Agents | 1 | 2016 | 13 | 0.140 |
Why?
| | Ventral Striatum | 1 | 2016 | 8 | 0.140 |
Why?
| | Intestinal Mucosa | 2 | 2000 | 525 | 0.140 |
Why?
| | Staphylococcus aureus | 1 | 2000 | 393 | 0.140 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 154 | 0.140 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2017 | 1159 | 0.140 |
Why?
| | Neuroendocrine Tumors | 1 | 2016 | 83 | 0.130 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2013 | 134 | 0.130 |
Why?
| | Flow Cytometry | 4 | 2011 | 1063 | 0.130 |
Why?
| | Female | 11 | 2021 | 60635 | 0.120 |
Why?
| | Cell Lineage | 4 | 2013 | 314 | 0.120 |
Why?
| | Gene Knock-In Techniques | 1 | 2014 | 47 | 0.120 |
Why?
| | Heterografts | 1 | 2014 | 124 | 0.120 |
Why?
| | Protein Interaction Mapping | 1 | 2014 | 104 | 0.120 |
Why?
| | CD48 Antigen | 1 | 2013 | 2 | 0.120 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2013 | 9 | 0.110 |
Why?
| | Histone Acetyltransferases | 1 | 2014 | 53 | 0.110 |
Why?
| | Leukocytosis | 1 | 2013 | 34 | 0.110 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 818 | 0.110 |
Why?
| | Action Potentials | 1 | 2016 | 418 | 0.110 |
Why?
| | Epistasis, Genetic | 1 | 2013 | 72 | 0.110 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 184 | 0.110 |
Why?
| | Cell Survival | 3 | 2019 | 1030 | 0.110 |
Why?
| | Memory, Short-Term | 1 | 2015 | 222 | 0.110 |
Why?
| | Capillaries | 1 | 2012 | 100 | 0.110 |
Why?
| | Capillary Permeability | 1 | 2012 | 136 | 0.100 |
Why?
| | Bone Marrow Cells | 1 | 2013 | 273 | 0.100 |
Why?
| | Prefrontal Cortex | 1 | 2015 | 264 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 399 | 0.100 |
Why?
| | Protein Binding | 1 | 2017 | 1949 | 0.100 |
Why?
| | Blood Proteins | 1 | 2012 | 235 | 0.090 |
Why?
| | Lysine | 1 | 2012 | 246 | 0.090 |
Why?
| | Membrane Proteins | 2 | 2013 | 1040 | 0.090 |
Why?
| | Anxiety | 1 | 2016 | 857 | 0.090 |
Why?
| | Pancreatic Neoplasms | 1 | 2016 | 716 | 0.090 |
Why?
| | Atherosclerosis | 1 | 2013 | 343 | 0.090 |
Why?
| | Mutation | 4 | 2015 | 3420 | 0.080 |
Why?
| | Cell Cycle | 2 | 2011 | 546 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2012 | 719 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 965 | 0.080 |
Why?
| | Erythroid Precursor Cells | 1 | 2007 | 4 | 0.080 |
Why?
| | Neurogenesis | 1 | 2009 | 104 | 0.080 |
Why?
| | Myeloid Progenitor Cells | 1 | 2007 | 16 | 0.080 |
Why?
| | Chimera | 1 | 2007 | 59 | 0.080 |
Why?
| | Cognition | 1 | 2014 | 988 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2021 | 9257 | 0.070 |
Why?
| | Animals, Newborn | 3 | 2016 | 797 | 0.070 |
Why?
| | Sequence Deletion | 1 | 2007 | 168 | 0.070 |
Why?
| | Cell Count | 1 | 2007 | 308 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 362 | 0.070 |
Why?
| | Cell Line | 3 | 2007 | 2670 | 0.070 |
Why?
| | Exons | 1 | 2007 | 302 | 0.070 |
Why?
| | Myeloid Cells | 1 | 2007 | 128 | 0.070 |
Why?
| | Endothelium, Vascular | 1 | 2012 | 860 | 0.070 |
Why?
| | Bone Marrow | 1 | 2007 | 250 | 0.070 |
Why?
| | Cell Death | 1 | 2007 | 333 | 0.070 |
Why?
| | Models, Biological | 1 | 2013 | 1689 | 0.070 |
Why?
| | Nerve Tissue Proteins | 3 | 2016 | 540 | 0.070 |
Why?
| | Biomarkers | 2 | 2013 | 3549 | 0.060 |
Why?
| | Myeloproliferative Disorders | 1 | 2005 | 25 | 0.060 |
Why?
| | Killer Cells, Natural | 2 | 2004 | 378 | 0.060 |
Why?
| | Mesonephros | 1 | 2004 | 5 | 0.060 |
Why?
| | Galactosides | 1 | 2004 | 3 | 0.060 |
Why?
| | Signaling Lymphocytic Activation Molecule Family | 1 | 2004 | 3 | 0.060 |
Why?
| | Phenotype | 4 | 2013 | 2891 | 0.060 |
Why?
| | Leukocyte Common Antigens | 1 | 2004 | 76 | 0.060 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2004 | 54 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2021 | 2814 | 0.060 |
Why?
| | Antigens, CD34 | 1 | 2004 | 98 | 0.060 |
Why?
| | Gene Transfer Techniques | 1 | 2004 | 153 | 0.060 |
Why?
| | Coculture Techniques | 1 | 2004 | 204 | 0.060 |
Why?
| | In Situ Hybridization | 1 | 2004 | 301 | 0.060 |
Why?
| | Cell Nucleus Structures | 1 | 2003 | 3 | 0.060 |
Why?
| | Stem Cell Transplantation | 1 | 2004 | 151 | 0.050 |
Why?
| | Polycomb-Group Proteins | 1 | 2023 | 36 | 0.050 |
Why?
| | Myeloid Ecotropic Viral Integration Site 1 Protein | 2 | 2016 | 12 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 761 | 0.050 |
Why?
| | Mice, Inbred CBA | 2 | 2000 | 56 | 0.050 |
Why?
| | Indoles | 1 | 2004 | 311 | 0.050 |
Why?
| | Time Factors | 3 | 2013 | 6240 | 0.050 |
Why?
| | Aorta | 1 | 2004 | 358 | 0.050 |
Why?
| | Liver | 2 | 2011 | 1744 | 0.050 |
Why?
| | Zebrafish Proteins | 1 | 2003 | 248 | 0.050 |
Why?
| | Oncogenes | 1 | 2021 | 110 | 0.050 |
Why?
| | Genome | 1 | 2023 | 269 | 0.050 |
Why?
| | Catalytic Domain | 1 | 2021 | 205 | 0.050 |
Why?
| | Nuclear Proteins | 1 | 2005 | 591 | 0.050 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2000 | 48 | 0.050 |
Why?
| | Drug Discovery | 1 | 2021 | 122 | 0.050 |
Why?
| | Drug Design | 1 | 2021 | 155 | 0.050 |
Why?
| | Protein Domains | 1 | 2021 | 212 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2021 | 414 | 0.040 |
Why?
| | Mice, Inbred C3H | 1 | 2000 | 240 | 0.040 |
Why?
| | Zebrafish | 1 | 2003 | 419 | 0.040 |
Why?
| | Clone Cells | 1 | 2000 | 247 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1657 | 0.040 |
Why?
| | Gene Targeting | 1 | 2019 | 76 | 0.040 |
Why?
| | Immunity, Cellular | 1 | 2000 | 267 | 0.040 |
Why?
| | Loss of Heterozygosity | 1 | 2016 | 40 | 0.040 |
Why?
| | Models, Molecular | 1 | 2021 | 1405 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2000 | 674 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 2016 | 156 | 0.030 |
Why?
| | Locomotion | 1 | 2016 | 82 | 0.030 |
Why?
| | Male | 6 | 2019 | 56664 | 0.030 |
Why?
| | Prosencephalon | 1 | 2015 | 48 | 0.030 |
Why?
| | Pyramidal Cells | 1 | 2015 | 51 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2016 | 860 | 0.030 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 145 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2015 | 310 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2000 | 977 | 0.030 |
Why?
| | Genotype | 2 | 2013 | 1854 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2013 | 45 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2013 | 81 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2013 | 64 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1053 | 0.030 |
Why?
| | Caveolae | 1 | 2012 | 16 | 0.030 |
Why?
| | Circadian Rhythm | 1 | 2016 | 392 | 0.030 |
Why?
| | Protein-Losing Enteropathies | 1 | 2012 | 10 | 0.030 |
Why?
| | Antipsychotic Agents | 1 | 2014 | 184 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 159 | 0.030 |
Why?
| | Behavior, Animal | 1 | 2015 | 476 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 274 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3390 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2014 | 392 | 0.020 |
Why?
| | Integrases | 1 | 2011 | 120 | 0.020 |
Why?
| | Islets of Langerhans | 1 | 2016 | 729 | 0.020 |
Why?
| | Schizophrenia | 1 | 2014 | 417 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1466 | 0.020 |
Why?
| | Translocation, Genetic | 1 | 2010 | 88 | 0.020 |
Why?
| | Molecular Sequence Data | 2 | 2005 | 2817 | 0.020 |
Why?
| | Oligodendrocyte Transcription Factor 2 | 1 | 2009 | 18 | 0.020 |
Why?
| | Cell Membrane | 1 | 2012 | 681 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1172 | 0.020 |
Why?
| | Antigens, Surface | 2 | 2005 | 151 | 0.020 |
Why?
| | Neuroglia | 1 | 2009 | 150 | 0.020 |
Why?
| | Cell Separation | 2 | 2005 | 293 | 0.020 |
Why?
| | Fetus | 1 | 2011 | 703 | 0.020 |
Why?
| | Olfactory Bulb | 1 | 2009 | 123 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 219 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2014 | 2038 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2016 | 3648 | 0.020 |
Why?
| | Coronaviridae Infections | 1 | 1986 | 3 | 0.020 |
Why?
| | G(M1) Ganglioside | 1 | 1986 | 7 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 2006 | 151 | 0.020 |
Why?
| | Blotting, Southern | 1 | 2005 | 66 | 0.020 |
Why?
| | Cell Transplantation | 1 | 2005 | 36 | 0.020 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1986 | 193 | 0.020 |
Why?
| | CREB-Binding Protein | 1 | 2005 | 26 | 0.020 |
Why?
| | Transgenes | 1 | 2005 | 173 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1588 | 0.020 |
Why?
| | Mesoderm | 1 | 2005 | 142 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2006 | 340 | 0.020 |
Why?
| | Spleen | 1 | 2005 | 488 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2014 | 6454 | 0.010 |
Why?
| | Body Patterning | 1 | 2003 | 128 | 0.010 |
Why?
| | Base Sequence | 1 | 2006 | 2123 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2003 | 524 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 2003 | 199 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2003 | 219 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1258 | 0.010 |
Why?
| | DNA | 1 | 2005 | 1372 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2003 | 2032 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2003 | 683 | 0.010 |
Why?
| | Aged | 1 | 2014 | 19359 | 0.010 |
Why?
| | Kidney | 1 | 2003 | 1344 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2003 | 2632 | 0.010 |
Why?
| | Middle Aged | 1 | 2014 | 27173 | 0.010 |
Why?
| | Centrifugation, Density Gradient | 1 | 1986 | 41 | 0.000 |
Why?
| | Mice, Inbred A | 1 | 1986 | 45 | 0.000 |
Why?
| | Glycosphingolipids | 1 | 1986 | 10 | 0.000 |
Why?
| | Immune Sera | 1 | 1986 | 80 | 0.000 |
Why?
| | Mice, Inbred DBA | 1 | 1986 | 172 | 0.000 |
Why?
| | Adult | 1 | 2006 | 31003 | 0.000 |
Why?
| | Epithelium | 1 | 1986 | 302 | 0.000 |
Why?
| | Colitis | 1 | 1986 | 219 | 0.000 |
Why?
|
|
Ernst's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|